Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Boston Trust Walden Corp Lowers Holdings in Amgen Inc. $AMGN
06:14am, Wednesday, 31'st Dec 2025
Boston Trust Walden Corp trimmed its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 56.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities a
Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC
05:34am, Wednesday, 31'st Dec 2025
Calamos Wealth Management LLC lifted its position in Amgen Inc. (NASDAQ: AMGN) by 136.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchan
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
02:26pm, Tuesday, 30'th Dec 2025
AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.
Can Amgen's MariTide Take on Leaders in the Obesity Space?
12:05pm, Tuesday, 30'th Dec 2025
AMGN's MariTide enters late-stage obesity trials with monthly dosing but faces rising competition as Eli Lilly and Novo Nordisk push oral GLP-1s.
Diversified Trust Co Has $12.05 Million Stock Position in Amgen Inc. $AMGN
05:10am, Tuesday, 30'th Dec 2025
Diversified Trust Co grew its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 8.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Com
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 29'th Dec 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Carnegie Investment Counsel Has $30.27 Million Stake in Amgen Inc. $AMGN
06:20am, Saturday, 27'th Dec 2025
Carnegie Investment Counsel boosted its stake in Amgen Inc. (NASDAQ: AMGN) by 5.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. Th
Amgen Inc. $AMGN Shares Acquired by Ellsworth Advisors LLC
05:03am, Saturday, 27'th Dec 2025
Ellsworth Advisors LLC lifted its position in Amgen Inc. (NASDAQ: AMGN) by 6.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm
Can Amgen Sustain Its Rally In 2026
01:03pm, Friday, 26'th Dec 2025
Amgen Inc. ends 2025 on a high note. Thanks to strong sales of Repatha and Imdelltra, it raised its full-year 2025 revenue guidance from $35-$36 billion to $35.8-$36.6 billion. So, sales of Repatha, a
Dogs of the Dow Beat the Market in 2025 — Here's the Smarter 4-Stock Play for 2026
09:50am, Thursday, 25'th Dec 2025
Keeping things simple when investing is often best, which is why buying an index fund can be the optimal strategy.
Brookstone Capital Management Acquires 16,042 Shares of Amgen Inc. $AMGN
05:34am, Thursday, 25'th Dec 2025
Brookstone Capital Management increased its holdings in Amgen Inc. (NASDAQ: AMGN) by 29.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exch
Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC
03:19am, Thursday, 25'th Dec 2025
Alpine Woods Capital Investors LLC lowered its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 15.9% during the third quarter, according to the company in its most recent disclosure with the Securitie
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know
11:36am, Wednesday, 24'th Dec 2025
AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment.
Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?
11:16am, Tuesday, 23'rd Dec 2025
NVO and AMGN square off as GLP-1 leadership, pipeline depth, and diversification set up a compelling healthcare stock comparison.
5 Big Drug Stocks That May Continue to Outperform in 2026
09:51am, Tuesday, 23'rd Dec 2025
Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.
